301293.SZ
三博脑科
SZSE · Q 卫生 · CN
CNY 50.55
−2.73%Year over year
Reported trailing growth
- Revenue
- +19.6%
- EBITDA
- —
- EBIT
- -36.5%
- EPS
- -45.2%
- Free cash flow
- +36.6%
- Operating cash flow
- +70.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +17.3%
- EBITDA
- +16.0%
- EBIT
- +11.7%
- Net income
- +9.9%
- EPS
- -8.2%
- Free cash flow
- -4.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026